The results obtained support the use of Trikafta/Kaftrio also in the treatment of pancreatic symptoms of CF and confirm that ALI/LLI-cultured CFPAC-1 cells are a reliable and flexible in vitro model for the study of CFTR rescue and epithelial physiology in the context of the pancreas. This evidence concerns the gene CFTR and cystic fibrosis.